These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 12673185)

  • 1. Pharmacologic stress testing: new methods and new agents.
    Hendel RC; Jamil T; Glover DK
    J Nucl Cardiol; 2003; 10(2):197-204. PubMed ID: 12673185
    [No Abstract]   [Full Text] [Related]  

  • 2. Biokinetics of thallium-201 in normal subjects: comparison between adenosine, dipyridamole, dobutamine and exercise.
    Lee J; Chae SC; Lee K; Heo J; Iskandrian AS
    J Nucl Med; 1994 Apr; 35(4):535-41. PubMed ID: 8151371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological cardiac stress: when and how?
    Pennell DJ
    Nucl Med Commun; 1994 Aug; 15(8):578-85. PubMed ID: 7970439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myocardial perfusion imaging during pharmacologic stress testing.
    Mahmarian JJ; Verani MS
    Cardiol Clin; 1994 May; 12(2):223-45. PubMed ID: 8033174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of pharmacologic stress testing for myocardial perfusion imaging.
    Cerqueira Mde C
    Rev Port Cardiol; 2000 Feb; 19 Suppl 1():I23-8. PubMed ID: 10750436
    [No Abstract]   [Full Text] [Related]  

  • 6. Whole-body imaging of thallium-201 after six different stress regimens.
    Pennell DJ; Ell PJ
    J Nucl Med; 1994 Mar; 35(3):425-8. PubMed ID: 8113888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of intravenous dipyridamole-thallium-201 imaging (1985 to 1994) and dobutamine echocardiography (1991 to 1994) for risk stratification before vascular surgery.
    Shaw LJ; Eagle KA; Gersh BJ; Miller DD
    J Am Coll Cardiol; 1996 Mar; 27(4):787-98. PubMed ID: 8613604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipyridamole and dobutamine-atropine stress echocardiography in the diagnosis of coronary artery disease. Comparison with exercise stress test, analysis of agreement, and impact of antianginal treatment.
    San Román JA; Vilacosta I; Castillo JA; Rollán MJ; Peral V; Sánchez-Harguindey L; Fernández-Avilés F
    Chest; 1996 Nov; 110(5):1248-54. PubMed ID: 8915229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic stress testing: experience with dipyridamole, adenosine, and dobutamine.
    McGuinness ME; Talbert RL
    Am J Hosp Pharm; 1994 Feb; 51(3):328-46; quiz 404-5. PubMed ID: 8160685
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of exercise, dipyridamole, adenosine, and dobutamine stress with the use of Tc-99m tetrofosmin tomographic imaging.
    Levine MG; Ahlberg AW; Mann A; White MP; McGill CC; Mendes de Leon C; Piriz JM; Waters D; Heller GV
    J Nucl Cardiol; 1999; 6(4):389-96. PubMed ID: 10461605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of exercise, dobutamine-atropine and dipyridamole-atropine stress echocardiography in detecting coronary artery disease.
    Nedeljkovic I; Ostojic M; Beleslin B; Djordjevic-Dikic A; Stepanovic J; Nedeljkovic M; Stojkovic S; Stankovic G; Saponjski J; Petrasinovic Z; Giga V; Mitrovic P
    Cardiovasc Ultrasound; 2006 May; 4():22. PubMed ID: 16672046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the long-term reproducibility of baseline and dobutamine-induced myocardial blood flow in patients with stable coronary artery disease.
    Jagathesan R; Kaufmann PA; Rosen SD; Rimoldi OE; Turkeimer F; Foale R; Camici PG
    J Nucl Med; 2005 Feb; 46(2):212-9. PubMed ID: 15695778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasodilator myocardial imaging.
    Pitt B
    Circulation; 1990 Jul; 82(1):308-9. PubMed ID: 2364518
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of pharmacologic stress agents.
    Leppo JA
    J Nucl Cardiol; 1996; 3(6 Pt 2):S22-6. PubMed ID: 8989683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological stress testing.
    Travain MI; Wexler JP
    Semin Nucl Med; 1999 Oct; 29(4):298-318. PubMed ID: 10534233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of caffeine on vasodilator stress perfusion studies.
    Lapeyre AC; Goraya TY; Johnston DL; Gibbons RJ
    J Nucl Cardiol; 2004; 11(4):506-11. PubMed ID: 15295419
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacologic perfusion imaging. Who needs it and why?
    Baig MW
    Postgrad Med; 1992 Jan; 91(1):185-7, 190-2. PubMed ID: 1728773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic stress echocardiography in the assessment of coronary artery disease.
    Picano E; Trivieri MG
    Curr Opin Cardiol; 1999 Nov; 14(6):464-70. PubMed ID: 10579061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacologic stress testing for coronary disease diagnosis: A meta-analysis.
    Kim C; Kwok YS; Heagerty P; Redberg R
    Am Heart J; 2001 Dec; 142(6):934-44. PubMed ID: 11717594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic radionuclide myocardial perfusion imaging.
    Navare SM; Kapetanopoulos A; Heller GV
    Curr Cardiol Rep; 2003 Jan; 5(1):16-24. PubMed ID: 12493156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.